First Turn Management »

Relay Therapeutics shares owned by First Turn Management

Quarter-by-quarter ownership of Relay Therapeutics (RLAY) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Relay Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relay Therapeutics held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relay Therapeutics by First Turn Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.7M 1.2M 7.08

More positions owned by First Turn Management

Nuvalent Inc-a (NUVL)
Argenx Se Sponsored Adr (ARGX)
Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
Vaxcyte (PCVX)
Axsome Therapeutics (AXSM)
Syndax Pharmaceuticals (SNDX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Natera (NTRA)
Intra Cellular Therapies (ITCI)
Crinetics Pharmaceuticals In (CRNX)
Transmedics Group (TMDX)
Arcellx Common Stock (ACLX)
Blueprint Medicines (BPMC)
Verona Pharma Sponsored Ads (VRNA)

View all positions for First Turn Management

Top funds holding Relay Therapeutics

BlackRock
Vanguard Group
BlackRock
Casdin Capital
Bellevue Group
Jpmorgan Chase & Co
T. Rowe Price Associates
State Street Corporation
Nextech Invest
Tang Capital Management
Braidwell
Citadel Advisors
Geode Capital Management
Eventide Asset Management
Boxer Capital

View all funds holding Relay Therapeutics